思路迪医药股份有限公司（股票代码：01244）于2026年6月3日公布截至2026年5月31日的股份变动月报表。报告期内，公司法定注册股本维持在500,000港元，普通股每股面值0.001港元，合计注册股份数目500,000,000股，注册股本和面值未发生变化。
公司已发行股份数量截至5月末为258,177,000股，与上一个月末持平，本月内未出现新增发行、购回、注销或库藏股相关变动。公司确认已维持符合在香港联交所的相关公开发售和公众持股量要求。
在股份期权及股权激励方面，公司当月股份期权数量为12,802,850份，与上月保持一致，未有行权、授出或失效记录。至本月末，相关期权尚无实际行使或转让情况，未导致公司已发行股份变化。
公司强调，所有证券发行及股份变动情况均严格遵守香港联交所《上市规则》及适用法律法规。本月报表由公司董事龚兆龙签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.